UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000016050
Receipt No. R000018654
Official scientific title of the study A clinical for evaluating the effect of L-citrulline and PDE5 inhibitor on erectile dysfunction and dysuria
Date of disclosure of the study information 2014/12/25
Last modified on 2018/12/27 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A clinical for evaluating the effect of L-citrulline and PDE5 inhibitor on erectile dysfunction and dysuria
Title of the study (Brief title) A clinical for evaluating the effect of L-citrulline on erectile dysfunction and dysuria
Region
Japan

Condition
Condition Benign Prostatic Hyperplasia
Classification by specialty
Urology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effect of L-citrulline and PDE5 inhibitor intake for 8weeks on the function of corpus cavernosum and dysuria
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Erectile function (IIEF,EHS)
Key secondary outcomes IPSS,OABSS,frequency volume chart,UFM,residual urine,SEP2, SEP3, GAQ,VAS,blood biochemistry

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Intake of L-citruline for 8weeks
Interventions/Control_2 Intake of placebo for 8weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
45 years-old <=
Age-upper limit
75 years-old >=
Gender Male
Key inclusion criteria 1.Subject aged from 45 to 75 years
2.Subject taking PDE5 inhibitor for 4weeks to treat Benign Prostatic Hyperplasia.
3.Subject classified IIEF score 8 to 25
4.Subject having sexual intercourse at least once a 8 week.
Key exclusion criteria 1.Subject receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders
2.Subject having a neurological disease
3.Subject having penile organic dysfunction
4.Subject having endocrine disease
5.Subject injecting insulin
6.Subject receiving hormone replacement therapy
7.Subject diagnosed psychogenic ED
8.Subject having the habit of taking a L-citrulline
9.Subject judged to be ineligible by the investigator for other reason
Target sample size 40

Research contact person
Name of lead principal investigator Kazunori Kimura
Organization Graduate School of Medical Sciences, Nagoya City University
Division name Department of Clinical Pharmacy
Address 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya
TEL 052-851-5511
Email kkimura@med.nagoya-cu.ac.jp

Public contact
Name of contact person Kazunori Kimura
Organization Graduate School of Medical Sciences, Nagoya City University
Division name Department of Clinical Pharmacy
Address 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya
TEL 052-851-5511
Homepage URL
Email kkimura@med.nagoya-cu.ac.jp

Sponsor
Institute Nagoya City University Hospital
Institute
Department

Funding Source
Organization KYOWA HAKKO BIO CO., LTD
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 12 Month 25 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 12 Month 08 Day
Anticipated trial start date
2015 Year 01 Month 04 Day
Last follow-up date
2017 Year 11 Month 30 Day
Date of closure to data entry
Date trial data considered complete
2018 Year 05 Month 31 Day
Date analysis concluded
2018 Year 08 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 12 Month 24 Day
Last modified on
2018 Year 12 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018654